×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Asthma Inhaler Device Market

ID: MRFR/HC/54552-HCR
200 Pages
MRFR Team
June 2025

France Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

France Asthma Inhaler Device Market Summary

Industry Developments

The France Asthma Inhaler Device Market is currently witnessing significant developments. The market has seen innovative product introductions, including smart inhalers that utilize digital health technology to enhance patient adherence and management of asthma symptoms. Companies like AstraZeneca and GlaxoSmithKline have been at the forefront of these advancements, integrating new technologies into their existing inhaler portfolios. In recent months, in September 2023, Teva Pharmaceutical Industries announced a collaboration with a leading digital health firm to enhance patient engagement through smart inhalation devices.In the realm of mergers and acquisitions, no significant deals have been reported recently among the major players in the French Asthma Inhaler Device Market. However, the overall market valuation has been positively impacted by the increasing prevalence of asthma in France, which has reportedly reached around 4 million patients as of early 2023. Companies such as Sanofi and Novartis are focusing on expanding their market reach through Research and Development initiatives, aimed at producing more personalized inhalation therapies. These trends reflect a dynamic market landscape, responding proactively to the evolving needs of asthma patients in France.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 201858.8(USD Million)
MARKET SIZE 202464.68(USD Million)
MARKET SIZE 2035112.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.118% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDPfizer, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, Mylan, Novartis, Sanofi, Merck KGaA, Havard Bioscience, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, AstraZeneca, Allergan
SEGMENTS COVEREDType, Mode of Operation, End User
KEY MARKET OPPORTUNITIESInnovative digital inhaler solutions, Increased demand for smart devices, Growing prevalence of asthma, Expansion of telehealth services, Rising awareness about asthma management
KEY MARKET DYNAMICSrising asthma prevalence, increasing healthcare expenditure, technological advancements, government initiatives, growing awareness of respiratory health
COUNTRIES COVEREDFrance

Leave a Comment

FAQs

What is the market size of the France Asthma Inhaler Device Market in 2024?

The France Asthma Inhaler Device Market is expected to be valued at 64.68 million USD in 2024.

What is the projected market size for the France Asthma Inhaler Device Market in 2035?

The market is projected to reach 112.0 million USD by the year 2035.

What is the expected compound annual growth rate (CAGR) for the France Asthma Inhaler Device Market from 2025 to 2035?

The expected CAGR for the market is 5.118% during the forecast period from 2025 to 2035.

Which type of inhalers is expected to dominate the market share in 2024?

Metered Dose Inhalers are expected to dominate the market with a valuation of 28.0 million USD in 2024.

What is the market value of Dry Powder Inhalers in 2035?

The market value of Dry Powder Inhalers is expected to reach 40.0 million USD by 2035.

Who are the key players in the France Asthma Inhaler Device Market?

Major players in the market include Pfizer, GlaxoSmithKline, Roche, and AstraZeneca among others.

What is the market value for Soft Mist Inhalers in 2024?

Soft Mist Inhalers are valued at 12.68 million USD in the year 2024.

What are the growth drivers for the France Asthma Inhaler Device Market?

Growth drivers include increasing prevalence of asthma, advancements in inhaler technology, and rising awareness among patients.

What has been the impact of the current global scenario on the France Asthma Inhaler Device Market?

Current global scenarios and conflicts may influence supply chains and pricing within the France Asthma Inhaler Device Market.

What is the expected market growth rate for Metered Dose Inhalers during the forecast period?

Metered Dose Inhalers are anticipated to see significant growth as they are projected to reach a market value of 46.0 million USD in 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions